4 results match your criteria: "Massachusetts General Hospital Bipolar Clinic and Research Program[Affiliation]"
Acta Psychiatr Scand
August 2016
Massachusetts General Hospital Bipolar Clinic and Research Program, Harvard Medical School, Boston, MA, USA.
Objectives: Few prospective studies examine the impact of ethnicity or race on outcomes with lithium for bipolar disorder. This exploratory study examines differences in lithium response and treatment outcomes in Hispanics, African Americans, and non-Hispanic whites with bipolar disorder in the Lithium Treatment Moderate Dose Use Study (LiTMUS).
Methods: LiTMUS was a six-site randomized controlled trial of low-dose lithium added to optimized treatment (OPT; personalized, evidence-based pharmacotherapy) vs.
CNS Spectr
February 2010
Massachusetts General Hospital Bipolar Clinic and Research Program, National Institute of Mental Health Bipolar Trials Network and Harvard Medical School, Boston, MA, USA.
Am J Psychiatry
February 2006
Massachusetts General Hospital Bipolar Clinic and Research Program, Suite 580, 50 Staniford Street, Boston, MA 02114, USA.
Objective: Clinicians have few evidence-based options for the management of treatment-resistant bipolar depression. This study represents the first randomized trial of competing options for treatment-resistant bipolar depression and assesses the effectiveness and safety of antidepressant augmentation with lamotrigine, inositol, and risperidone.
Method: Participants (N=66) were patients with bipolar I or bipolar II disorder enrolled in the NIMH Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).